Involvement of chymase-mediated angiotensin II generation in blood pressure regulation

The Journal of Clinical Investigation
Ming LiAhsan Husain

Abstract

Angiotensin I-converting enzyme (ACE) inhibitors are thought to lower blood pressure in hypertensive patients, mainly by decreasing angiotensin II (Ang II) formation. Chymase, a human mast cell protease, has recently been proposed to play a role in blood pressure regulation because of its Ang II-forming activity. Here we show that the predominant chymase mRNA species in the mouse aorta are those for types 4 and 5 isoforms, and that both are efficient Ang II-forming enzymes. Evaluation of ACE-dependent and ACE-independent Ang II-forming pathways in mast cell-deficient (Kit(w)/Kit(w-v)) mice and their mast cell-sufficient littermate (MC(+/+)) controls revealed that, in contrast to the latter, Kit(w)/Kit(w-v) mice fail to express chymase mRNAs in the vasculature and have almost no ACE-independent Ang II-forming activity in either isolated blood vessels or homogenates. Moreover, in MC(+/+) but not in Kit(w)/Kit(w-v) mice, a contribution of ACE-independent Ang II generation to blood pressure regulation was evident by a 1.6-fold greater maximal reduction in mean arterial pressure with acute ACE inhibition plus AT(1) receptor blockade than with ACE inhibition alone. Thus, mast cells are the source of the vascular ACE-independent pathw...Continue Reading

References

Apr 1, 1990·Circulation Research·H UrataA Husain
Sep 1, 1995·The Journal of Clinical Investigation·L S ZismanM V Raynolds
Apr 1, 1993·The Journal of Clinical Investigation·H UrataA Husain
Jan 4, 1994·Proceedings of the National Academy of Sciences of the United States of America·R L StevensK F Austen
Jul 1, 1993·Circulation Research·A KinoshitaA Husain
Jan 26, 1996·Science·U M ChandrasekharanA Husain
Jul 19, 2000·Biochimica Et Biophysica Acta·G H CaugheyP J Wolters
Mar 20, 2001·The Journal of Clinical Investigation·C GuoM Rabinovitch
Jun 21, 2001·Proceedings of the National Academy of Sciences of the United States of America·H JuM Rabinovitch
Jan 19, 2002·Hypertension·Akira NishiyamaL Gabriel Navar
Aug 2, 2002·Current Opinion in Cardiology·Louis J Dell'Italia, Ahsan Husain
Oct 5, 2002·Hypertension·Robert E WiddopDaniel Henrion
Jul 16, 2003·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·A D PembertonH R P Miller
Oct 11, 2003·Molecular Cell·Merridee A WoutersAhsan Husain

❮ Previous
Next ❯

Citations

Jun 22, 2006·Cardiology in Review·Christopher Bacani, William H Frishman
Feb 16, 2008·Current Opinion in Nephrology and Hypertension·Rajesh KumarKenneth M Baker
Dec 17, 2008·Current Opinion in Nephrology and Hypertension·Rajesh Kumar, Mirian A Boim
Oct 13, 2007·The Journal of Clinical Investigation·Jiusong SunGuo-Ping Shi
Mar 26, 2010·The Journal of Clinical Investigation·Chih-Chang WeiAhsan Husain
Aug 4, 2010·The Journal of Clinical Investigation·Ilka MatharMarc Freichel
Jun 11, 2014·Journal of the American Society of Hypertension : JASH·Daniel SilverbergJacob Schneiderman
Aug 12, 2014·Inflammation Research : Official Journal of the European Histamine Research Society ... [et Al.]·Mu-qing YangJi-yu Li
Nov 12, 2010·Cellular and Molecular Life Sciences : CMLS·Anders Lundequist, Gunnar Pejler
Mar 8, 2013·Cardiovascular Drugs and Therapy·Hideaki Tojo, Hidenori Urata
Jan 15, 2013·Journal of the American Society of Hypertension : JASH·Sarfaraz AhmadCarlos M Ferrario
Aug 5, 2008·Vascular Pharmacology·P D'Orléans-JusteE Simard
Oct 2, 2007·Vascular Pharmacology·Stephanie W WattsGregory D Fink
Jun 26, 2007·Lancet·Ali AhmedAhsan Husain
Sep 29, 2011·CNS Neuroscience & Therapeutics·Jian-Guang YuGuo-Jun Cai
Dec 8, 2009·Biological Reviews of the Cambridge Philosophical Society·Enrico Crivellato, Domenico Ribatti
Aug 3, 2005·Trends in Endocrinology and Metabolism : TEM·Frédérique Deshayes, Clara Nahmias
Sep 15, 2005·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Kazuyoshi KirimuraMizuo Miyazaki
May 11, 2015·European Journal of Pharmacology·George H Caughey
Jan 22, 2013·Pharmacology & Therapeutics·Simon KennedyPasquale Maffia
Aug 21, 2012·The American Journal of Pathology·Adrian M PiliponskyStephen J Galli
Apr 20, 2019·Frontiers in Immunology·Stephanie A LegereJean S Marshall
Aug 10, 2021·Frontiers in Cell and Developmental Biology·Xin LiuJunli Guo

❮ Previous
Next ❯

Methods Mentioned

BETA
transgenic
PCR
ion-exchange chromatography

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.